Use of a new enzyme-linked immunosorbent assay for the detection of type 2N von Willebrand disease and its prevalence in an Indian population

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 1, 2006, Pages 7-11

  Ghosh, Kanjaksha ^a   Trasi, Sucheta ^a   Shetty, Shrimati ^a   Mohanty, Dipika ^a  

^a KEM HOSPITAL   (India)

Author keywords

Enzyme linked immunosorbent assay; Type 2N von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; ARTICLE; BINDING ASSAY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; INTERMETHOD COMPARISON; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

ECONOMICS; FORECASTING; IMPULSE RESPONSE; INTEGRATION; REGRESSION ANALYSIS; STEEL;

COINTEGRATION; ECONOMIC GROWTH; GRANGER CAUSALITY; STEEL CONSUMPTION;

IRON AND STEEL INDUSTRY;

COINTEGRATION ANALYSIS; ECONOMIC GROWTH; GRANGER CAUSALITY TEST; STEEL; VECTOR AUTOREGRESSION;

ASIA; EURASIA; INDIA; SOUTH ASIA;

EID: 33747330174     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resourpol.2006.03.005     Document Type: Article

References (13)

1. Casonato A, Pontara E, Sartorello F, Bertomoro A, Girolami A. Interaction of factor VIII and von Willebrand factor investigated in a large cohort of von Willebrand disease patients: evaluation of the type 2N variant prevalence [abstract]. J Thromb Haemost 2003; 1:0093.
2. Budde U, Drewke E, Mainusch K, Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost 2002; 28:173-190.
3. Woods AI, Meschengieser SS, Blanco AN, Salviu MJ, Farias CE, Kempfer AC, Lazzari MA. Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrands disease. Haematologica 2001; 86:420-427.
4. Schneppenheim R, Budde U, Krey S, Drewik E, Bergmann F, Lechler E, et al. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type I. Thromb Hemost 1996; 76:598-602.
5. Nesbitt JM, Goodeve AC, Guilliatt AM, Macris M, Preston FE, Peake IR. Characterization of type 2N von Willebrand disease using phenotypic and molecular techniques. Thromb Haemost 1996; 75:959-964.
6. Casonato A, Pontata E, Zerbinati P, Zucchetto A, Girolami A. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol 1998; 109:347-352.
7. Lopez-Fernandez MF, Blanco-Lopez MJ, Casteneira MP, Battle J. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 1992; 40:20-27.
8. Miller CH, Kelley L, Green D. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Am J Hematol 1998; 58:311-318.
9. Nishino M, Girma J-P, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989; 74:1591-1599.
10. Mazurier C, Goudemand J, Hilbert L, Caron C, Fressinaud E. Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular pathology. Clin Haematol 2001; 14:337-347.
11. Caron C, Mazurier C, Goudemand J. Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents. Br J Haematol 2002; 117:716-718.
12. Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A, Goudemand M. Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemohilia A carriers. Consequences for therapy and genetic counseling. Br J Haematol 1990; 76:372-379.
13. Trasi S, Shetty S, Ghosh K, Mohanty D. Prevalence and spectrum of VWD from western India. Ind J Med Res 2005; 121:653-658.